Which has better valuation & earnings, BDSX or ITGR?

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biodesix $88.50M 1.26 -$35.26M -$2.76 N/A Integer $1.83B 2.36 $102.81M $2.98 42.52

Is BDSX or ITGR more profitable?

Integer has a net margin of 5.68% compared to Biodesix's net margin of -25.74%. Integer's return on equity of 11.84% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets Biodesix -25.74% -513.78% -29.28% Integer 5.68% 11.84% 5.98%

Does the media favor BDSX or ITGR?

In the previous week, Biodesix had 21 more articles in the media than Integer. MarketBeat recorded 22 mentions for Biodesix and 1 mentions for Integer. Integer's average media sentiment score of 1.76 beat Biodesix's score of -0.17 indicating that Integer is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodesix 0 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger valuation & earnings, ITGR or ELV?

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.83B 2.36 $102.81M $2.98 42.52 Elevance Health $201.83B 0.46 $5.66B $23.45 18.31

Does the media refer more to ITGR or ELV?

In the previous week, Elevance Health had 35 more articles in the media than Integer. MarketBeat recorded 36 mentions for Elevance Health and 1 mentions for Integer. Integer's average media sentiment score of 1.76 beat Elevance Health's score of 0.83 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Elevance Health 15 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, ITGR or GKOS?

Integer has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.83B 2.36 $102.81M $2.98 42.52 Glaukos $507.44M 27.63 -$187.69M -$2.94 N/A

Is ITGR or GKOS more profitable?

Integer has a net margin of 5.68% compared to Glaukos' net margin of -24.60%. Integer's return on equity of 11.84% beat Glaukos' return on equity. Company Net Margins Return on Equity Return on Assets Integer 5.68% 11.84% 5.98% Glaukos -24.60% -0.97% -0.71%

Does the media prefer ITGR or GKOS?

In the previous week, Glaukos had 8 more articles in the media than Integer. MarketBeat recorded 9 mentions for Glaukos and 1 mentions for Integer. Integer's average media sentiment score of 1.76 beat Glaukos' score of 0.44 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Glaukos 4 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor BAX or ITGR?

In the previous week, Baxter International had 10 more articles in the media than Integer. MarketBeat recorded 11 mentions for Baxter International and 1 mentions for Integer. Integer's average media sentiment score of 1.76 beat Baxter International's score of 1.01 indicating that Integer is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger earnings & valuation, PEN or ITGR?

Penumbra has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Penumbra $1.40B 9.03 $177.69M $3.97 80.97 Integer $1.83B 2.36 $102.81M $2.98 42.52

Is PEN or ITGR more profitable?

Penumbra has a net margin of 10.06% compared to Integer's net margin of 5.68%. Integer's return on equity of 11.84% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Penumbra 10.06% 10.39% 8.09% Integer 5.68% 11.84% 5.98%

Integer (ITGR) Competitors

$126.66 +0.05 (+0.04%)

As of 12:29 PM Eastern

Compare

ITGR vs. BDSX, ELV, GKOS, BAX, and PEN

Should you buy Integer stock or one of its competitors? Integer's main competitors and comparable companies include Biodesix (BDSX), Elevance Health (ELV), Glaukos (GKOS), Baxter International (BAX), and Penumbra (PEN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Integer compare to Biodesix?

Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

In the previous week, Biodesix had 21 more articles in the media than Integer. MarketBeat recorded 22 mentions for Biodesix and 1 mentions for Integer. Integer's average media sentiment score of 1.76 beat Biodesix's score of -0.17 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biodesix	0 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Integer has a net margin of 5.68% compared to Biodesix's net margin of -25.74%. Integer's return on equity of 11.84% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-25.74%	-513.78%	-29.28%
Integer	5.68%	11.84%	5.98%

Biodesix currently has a consensus price target of $34.20, indicating a potential upside of 241.32%. Integer has a consensus price target of $113.67, indicating a potential downside of 10.29%. Given Biodesix's stronger consensus rating and higher possible upside, research analysts clearly believe Biodesix is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86
Integer	0 Sell rating(s)	11 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.08

Biodesix has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market. Comparatively, Integer has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 23.2% of Biodesix shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$88.50M	1.26	-$35.26M	-$2.76	N/A
Integer	$1.83B	2.36	$102.81M	$2.98	42.52

Summary

Integer beats Biodesix on 10 of the 17 factors compared between the two stocks.

How does Integer compare to Elevance Health?

Integer (NYSE:ITGR) and Elevance Health (NYSE:ELV) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk.

Integer has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market.

Integer currently has a consensus target price of $113.67, indicating a potential downside of 10.29%. Elevance Health has a consensus target price of $456.48, indicating a potential upside of 6.29%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts clearly believe Elevance Health is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	11 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.08
Elevance Health	0 Sell rating(s)	7 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.68

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.83B	2.36	$102.81M	$2.98	42.52
Elevance Health	$201.83B	0.46	$5.66B	$23.45	18.31

In the previous week, Elevance Health had 35 more articles in the media than Integer. MarketBeat recorded 36 mentions for Elevance Health and 1 mentions for Integer. Integer's average media sentiment score of 1.76 beat Elevance Health's score of 0.83 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Elevance Health	15 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer has a net margin of 5.68% compared to Elevance Health's net margin of 2.55%. Elevance Health's return on equity of 14.97% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	5.68%	11.84%	5.98%
Elevance Health	2.55%	14.97%	5.31%

99.3% of Integer shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 0.3% of Elevance Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Elevance Health beats Integer on 9 of the 16 factors compared between the two stocks.

How does Integer compare to Glaukos?

Integer (NYSE:ITGR) and Glaukos (NYSE:GKOS) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

Integer has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market. Comparatively, Glaukos has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market.

Integer presently has a consensus price target of $113.67, suggesting a potential downside of 10.29%. Glaukos has a consensus price target of $216.71, suggesting a potential downside of 8.49%. Given Glaukos' stronger consensus rating and higher possible upside, analysts plainly believe Glaukos is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	11 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.08
Glaukos	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88

In the previous week, Glaukos had 8 more articles in the media than Integer. MarketBeat recorded 9 mentions for Glaukos and 1 mentions for Integer. Integer's average media sentiment score of 1.76 beat Glaukos' score of 0.44 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Glaukos	4 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integer has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.83B	2.36	$102.81M	$2.98	42.52
Glaukos	$507.44M	27.63	-$187.69M	-$2.94	N/A

99.3% of Integer shares are owned by institutional investors. Comparatively, 99.0% of Glaukos shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 5.9% of Glaukos shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Integer has a net margin of 5.68% compared to Glaukos' net margin of -24.60%. Integer's return on equity of 11.84% beat Glaukos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	5.68%	11.84%	5.98%
Glaukos	-24.60%	-0.97%	-0.71%

Summary

Integer beats Glaukos on 9 of the 17 factors compared between the two stocks.

How does Integer compare to Baxter International?

Baxter International (NYSE:BAX) and Integer (NYSE:ITGR) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

90.2% of Baxter International shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 0.2% of Baxter International shares are held by company insiders. Comparatively, 1.1% of Integer shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Baxter International had 10 more articles in the media than Integer. MarketBeat recorded 11 mentions for Baxter International and 1 mentions for Integer. Integer's average media sentiment score of 1.76 beat Baxter International's score of 1.01 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Baxter International presently has a consensus target price of $23.27, indicating a potential downside of 11.90%. Integer has a consensus target price of $113.67, indicating a potential downside of 10.29%. Given Integer's stronger consensus rating and higher possible upside, analysts clearly believe Integer is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	3 Sell rating(s)	10 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Integer	0 Sell rating(s)	11 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.08

Baxter International has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Integer has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

Integer has a net margin of 5.68% compared to Baxter International's net margin of -6.23%. Baxter International's return on equity of 16.23% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-6.23%	16.23%	5.08%
Integer	5.68%	11.84%	5.98%

Integer has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.22	-$957M	-$1.41	N/A
Integer	$1.83B	2.36	$102.81M	$2.98	42.52

Summary

Integer beats Baxter International on 11 of the 15 factors compared between the two stocks.

How does Integer compare to Penumbra?

Penumbra (NYSE:PEN) and Integer (NYSE:ITGR) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

In the previous week, Integer had 1 more articles in the media than Penumbra. MarketBeat recorded 1 mentions for Integer and 0 mentions for Penumbra. Integer's average media sentiment score of 1.76 beat Penumbra's score of 0.16 indicating that Integer is being referred to more favorably in the news media.

Company	Overall Sentiment
Penumbra	Neutral
Integer	Very Positive

Penumbra has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, Integer has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

88.9% of Penumbra shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 2.9% of Penumbra shares are held by insiders. Comparatively, 1.1% of Integer shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Penumbra has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.40B	9.03	$177.69M	$3.97	80.97
Integer	$1.83B	2.36	$102.81M	$2.98	42.52

Penumbra has a net margin of 10.06% compared to Integer's net margin of 5.68%. Integer's return on equity of 11.84% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	10.06%	10.39%	8.09%
Integer	5.68%	11.84%	5.98%

Penumbra currently has a consensus price target of $367.07, suggesting a potential upside of 14.19%. Integer has a consensus price target of $113.67, suggesting a potential downside of 10.29%. Given Penumbra's stronger consensus rating and higher possible upside, equities analysts plainly believe Penumbra is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
Integer	0 Sell rating(s)	11 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.08

Summary

Penumbra beats Integer on 11 of the 16 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ITGR vs. The Competition

Export

Metric	Integer	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$4.31B	$6.02B	$7.85B	$23.55B
Dividend Yield	N/A	1.69%	2.47%	3.73%
P/E Ratio	42.51	38.89	34.13	30.37
Price / Sales	2.36	5.45	8.50	3.40
Price / Cash	12.21	24.25	22.22	15.97
Price / Book	2.49	4.32	4.44	3.76
Net Income	$102.81M	$142.48M	$3.50B	$1.08B
7 Day Performance	0.02%	-1.93%	-0.93%	-0.66%
1 Month Performance	0.03%	-0.94%	-4.06%	0.99%
1 Year Performance	81.52%	-1.03%	1.52%	6.67%

Integer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ITGR Integer	1.2099 of 5 stars	$126.67 +0.0%	$113.67 -10.3%	+84.1%	$4.31B	$1.83B	42.51	11,000
BDSX Biodesix	3.7127 of 5 stars	$21.97 +0.9%	$36.25 +65.0%	+32.9%	$231.81M	$102.94M	N/A	334	Trending News Earnings Report Analyst Forecast Analyst Revision
ELV Elevance Health	4.7542 of 5 stars	$414.23 +0.2%	$456.48 +10.2%	+41.7%	$89.44B	$199.13B	17.65	97,100
GKOS Glaukos	2.5837 of 5 stars	$237.78 -0.3%	$216.71 -8.9%	+168.4%	$14.03B	$507.44M	N/A	1,094
BAX Baxter International	1.9341 of 5 stars	$24.51 +1.2%	$23.00 -6.1%	+48.8%	$12.67B	$11.61B	N/A	37,500	Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ITGR) was last updated on 11/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integer (ITGR) Competitors